08/05/2025
Hope for all pets !
Joy Paw Paw and Taiwan Bio Therapeutics Join Forces to Develop a Gene-Engineered Extracellular Vesicle Therapy for Pet Heart Disease. Taiwan Bio Therapeutics is applying human gene-engineered extracellular vesicle (EV) technology to the pet healthcare market, paving the way to potentially create the world’s first mechanism-based therapy for pet heart disease. This groundbreaking innovation brings new hope to pets and their owners worldwide.